SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EyeDrMike who wrote (2547)11/16/1997 8:44:00 PM
From: BigKNY3  Read Replies (1) of 23519
 
Eye: << Is the selling due to another reason?>>

Sorry to disappoint you but the PFE selling is not related to Viagra or anticipation of a PFE decline. The selling is a quarterly tradition by Pfizer executives and primarily has to do with expiration of their stock options. The selling occurs right after announcement of the quarterly earnings report. As with many corporate executives, instead of laying out money to purchase shares, the options are exerised and the shares immediately sold.

This quarter, the selling occurred around October 16th (PFE@ $67). Six days later, Viagra received its priority review from the FDA and PFE jumped to 72 3/8. The PFE executives probably wished that they didn't have to sell. However, they probably still hold major investments in their company.

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext